Skip to main content
Official EU label nameGlossary entry 3040

BARIUM HEXAFERRITE

This record confirms an official common ingredient name for EU cosmetic product labelling. It does not by itself confirm that the substance is permitted, unrestricted or safe.

Global evidence snapshot

The resolved identity has matching regulatory evidence in 0 of 13 indexed market datasets: 0 country records and 0 EU Annex records. Every result and evidence gap is listed below.

0 markets with evidence
Markets checked
13
Markets with evidence
0
Evidence gaps
13
Resolved identifiers
2

Resolved substance identity

CAS:12047-11-9
EC:234-974-5
Ingredient index records:
BARIUM HEXAFERRITE
Cosmetic functions: NOT REPORTED

Barium Iron Oxide

Inventory restriction note: II/46

1 matched or reported name
BARIUM HEXAFERRITE

Regulatory evidence across markets

None of the 13 markets tracked here holds an imported rule under the name BARIUM HEXAFERRITE.

That is a statement about this inventory, not about the law: no imported rule is not evidence that a substance is permitted. A rule may exist under a different name, under a CAS or EC number this glossary entry does not carry, or in a dataset not yet imported.

Chemical identity and properties

PubChem 2D chemical structure for CAS 12047-11-9
CAS 12047-11-9PubChem CID 159418

Barium hexaferrite

Barium ferrite is a chemical compound of barium and iron. It is used as a component in magnetic stripe cards. Barium is a metallic alkaline earth metal with the symbol Ba, and atomic number 56. It never occurs in nature in its pure form due to its reactivity with air, but combines with other chemicals such as sulfur or carbon and oxygen to form barium compounds that may be found as minerals. (L214, 408, L244) — Toxin and Toxin Target Database (T3DB)

IUPAC name
barium(2+);dodecakis(iron(3+));nonadecakis(oxygen(2-))
Molecular formula
BaFe12O19
Molecular weight
1111.5 g/mol
Exact mass
1113.02785 Da
Topological polar surface area
19.0 Ų
Hydrogen-bond donors
0
Hydrogen-bond acceptors
19
Covalent units
32
Defined stereocentres
0

Also known as

FerroxdureFerotop GP 5004HT629NL8BBarium ferrate (BaFe12O19)Barium iron oxide (BaFe12O19)RefChem:116527234-974-5barium(2+);iron(3+);oxygen(2-)
11 more reported names
Barium Iron Oxide Nanoparticles / NanopowderEINECS 234-974-5GP 500BaFe12O19UNII-4HT629NL8BFerrate (fe12-O19(sup 2-)), barium (1:1)HPYIMVBXZPJVBV-UHFFFAOYSA-Ndodecaferric;barium(2+);oxygen(2-)Barium Iron Oxide Nanoparticle DispersionEC 234-974-5FERRATE (FE12O192-), BARIUM (1:1)

Evidence from additional scientific databases

NIH PubChem PUG-View
Exact identifier match159418

Attributed physical-property, hazard, environmental and use annotations.

  • Note: This chemical does not meet GHS hazard criteria for 1.6% (1 of 63) of reports. Source: European Chemicals Agency (ECHA)
  • Signal: Warning Source: European Chemicals Agency (ECHA)
  • GHS Hazard Statements: H302+H332 (61.9%): Harmful if swallowed or if inhaled [Warning Acute toxicity, oral; acute toxicity, inhalation]; H302 (81%): Harmful if swallowed [Warning Acute toxicity, oral]; H332 (61.9%): Harmful if inhaled [Warning Acute toxicity, inhalation]; H371 (79.4%): May cause damage to organs [Warning Specific target organ toxicity, single exposure]; H373 (79.4%): May causes damage to organs through prolonged or repeated exposure [Warning Specific target organ toxicity, repeated exposure] Source: European Chemicals Agency (ECHA)
  • Precautionary Statement Codes: P260, P261, P264, P270, P271, P301+P317, P304+P340, P308+P316, P317, P319, P330, P405, and P501 (click each P-code to see the statement) Source: European Chemicals Agency (ECHA)
  • ECHA C&L Notifications Summary: Aggregated GHS information provided per 63 reports by companies from 6 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.; Reported as not meeting GHS hazard criteria per 1 of 63 reports by companies.; There are 5 notifications provided by 62 of 63 reports by companies with hazard statement code(s).; Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website. Source: European Chemicals Agency (ECHA)
  • GHS Hazard Statements: Not Classified; Reported as not meeting GHS hazard criteria by 1 of 1 companies. For more detailed information, please visit ECHA C&L website. Source: European Chemicals Agency (ECHA)
  • Health Effects: The health effects of the different barium compounds depend on how well the compound dissolves in water or the stomach contents. At low doses, barium acts as a muscle stimulant, while higher doses affect the nervous system, causing cardiac irregularities, tremors, weakness, anxiety, dyspnea, paralysisand possibly death. Barium may also cause gastrointestinal disturbances, damage the kidneys and cause decreases in body weight. (L214) Source: Toxin and Toxin Target Database (T3DB)
  • Toxicity Summary: Barium is a competitive potassium channel antagonist that blocks the passive efflux of intracellular potassium, resulting in a shift of potassium from extracellular to intracellular compartments. The intracellular translocation of potassium results in a decreased resting membrane potential, making the muscle fibers electrically unexcitable and causing paralysis. Some of these barium's effects may also be due to barium induced neuromuscular blockade and membrane depolarization. (L214) Source: Toxin and Toxin Target Database (T3DB)

Mapped by: Existing checksum-valid CAS to unique PubChem CID match. Retrieved: 2026-08-31. Open source record

Scientific classifications and hazard annotations provide context and do not replace the market-specific regulatory decision shown above.

Additional source coverage and match status
SourceResultChecked
NIH PubChem PUG-ViewExact match2026-08-31

A recorded no-match is useful evidence that the source was checked; it is not a claim that the substance does not exist elsewhere.

Retrieved from NIH PubChem on 2026-08-31 by checksum-valid CAS matching. Chemical properties do not replace the regulatory decision on this page.

Take this record further

Screen in a formulaOpen standalone comparison

Official source and scope

Imported from Commission Implementing Decision (EU) 2025/1175 (dataset version EU 2025/1175). The glossary supplies common ingredient names for the ingredient list required by Article 19(1)(g); it is not an approval or safety list.

Open official Decision